Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
ADMA Biologics Inc
ADMA Biologics Inc is a biopharmaceutical company. The company develops and manufactures specialty plasma-based biologics for the proposed treatment of immune deficiencies and prevention of certain infectious diseases.
IPO Date: October 18, 2013
Sector: Healthcare
Industry: Biotech
Market Cap: $4.29B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.15 | 2.78%
Avg Daily Range (30 D): $0.35 | 1.85%
Avg Daily Range (90 D): $0.45 | 2.30%
Institutional Daily Volume
Avg Daily Volume: 1.57M
Avg Daily Volume (30 D): 2.5M
Avg Daily Volume (90 D): 2.79M
Trade Size
Avg Trade Size (Sh.): 193
Avg Trade Size (Sh.) (30 D): 80
Avg Trade Size (Sh.) (90 D): 81
Institutional Trades
Total Inst.Trades: 1,692
Avg Inst. Trade: $3.39M
Avg Inst. Trade (30 D): $5.6M
Avg Inst. Trade (90 D): $4.47M
Avg Inst. Trade Volume: .33M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $5.22M
Avg Closing Trade (30 D): $10.77M
Avg Closing Trade (90 D): $9.75M
Avg Closing Volume: 508.19K
   
News
May 6, 2025 @ 8:11 PM
3 Mid-Cap Medical Stocks Outperforming the Market
Source: Marketbeat.Com
Apr 7, 2025 @ 11:00 AM
ADMA Biologics Statement on Tariffs
Source: N/A
Mar 4, 2025 @ 6:50 PM
BREAKING: Block & Leviton Investigating ADMA Biolo...
Source: Block & Leviton
Nov 2, 2024 @ 10:18 AM
BFA Law is Investigating ADMA BIOLOGICS for Securi...
Source: N/A
Oct 27, 2024 @ 12:06 PM
ADMA FRAUD ALERT: BFA Law Notifies ADMA Biologics ...
Source: N/A
Financials
  TTM Q4 2024 FY 2024
Basic EPS $.11 $.48 $.85
Diluted EPS $.11 $.46 $.81
Revenue $ 114.8M $ 117.55M $ 426.45M
Gross Profit $ 61.1M $ 63.33M $ 219.55M
Net Income / Loss $ 26.9M $ 111.9M $ 197.67M
Operating Income / Loss $ 34.88M $ 38.32M $ 138.98M
Cost of Revenue $ 53.71M $ 54.22M $ 206.9M
Net Cash Flow $ -31.52M $ 16.44M $ 51.8M
PE Ratio 0.00